Loading stock data…
Calidi Biotherapeutics (CLDI)
$0.16-0.00 (-1.23%)
After Hours$0.16+0.00 (+0.87%)· Last close Jun 29
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Calidi Biotherapeutics, Inc. in the Healthcare sector is trading at $0.16 with a market capitalization of $3M. The stock is currently near its 52-week low of $0.12, remaining 81.5% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$4.19M↑ | -$4.47M↑ | -$5.05M↑ | -$5.66M↓ | -$5.01M |
| Net Income | -$4.11M↓ | -$4.06M↑ | -$5.15M↑ | -$5.71M↓ | -$4.99M |
Peer Comparison
JNJUNHPFE
Fundamentals
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high gr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.02M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-385.57%
Volume
Today's trading volume
7.36M